STRS Ohio’s Ocular Therapeutix OCUL Stock Holding History

STRS Ohio’s Portfolio OCUL Stock Details OCUL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$374K	Hold	44,200	–	–	﹤0.01%	1233
2025 Q4	$537K	Buy	+44,200	New	+$537K	﹤0.01%	1038
2024 Q1	–	Sell	-38,200	Closed	-$170K	–	2000
2023 Q4	$170K	Hold	38,200	–	–	﹤0.01%	1607
2023 Q3	$119K	Hold	38,200	–	–	﹤0.01%	1677
2023 Q2	$197K	Sell	38,200 -19,700	-34%	-$117K	﹤0.01%	1591
2023 Q1	$305K	Buy	57,900 +42,000	+264%	+$199K	﹤0.01%	1503
2022 Q4	$44K	Hold	15,900	–	–	﹤0.01%	1818
2022 Q3	$65K	Buy	+15,900	New	+$80.1K	﹤0.01%	1808
2014 Q4	–	Sell	-2,000	Closed	-$30K	–	1785
2014 Q3	$30K	Buy	+2,000	New	+$29.6K	﹤0.01%	1708

Other funds holding OCUL

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

STRS Ohio's OCUL Position: Q1 2026 in Review

STRS Ohio held its Ocular Therapeutix (OCUL) position steady in Q1 2026 at 44,200 shares worth $374K. The position accounts for ﹤0.01% of the portfolio, ranked #1233.

STRS Ohio first reported a position in OCUL in Q3 2014 and has held it in 9 quarters since. The position peaked at $537K in Q4 2025. 269 funds tracked by Wall St. Rank hold OCUL as of Q1 2026.

STRS Ohio held 44,200 shares of Ocular Therapeutix worth $374K as of Q1 2026.
STRS Ohio left its Ocular Therapeutix share count unchanged in Q1 2026.
Ocular Therapeutix made up ﹤0.01% of STRS Ohio's portfolio in Q1 2026, its #1233 holding.
STRS Ohio first reported a position in Ocular Therapeutix in Q3 2014 and has held it in 9 quarters since.
STRS Ohio's Ocular Therapeutix position peaked at $537K in Q4 2025.
269 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q1 2026.

Based on STRS Ohio's 13F filing for Q1 2026, filed 24 Apr 2026.